Latest news

Clinical

Phase 3 NSCLC study for Pfizer’s first novel ADC from the acquisition of Seagen fails

The big gamble that Pfizer made on antibody-drug conjugates (ADCs) has gone sour.The pharma giant revealed that its first...
Insights

Top 10 Reasons Precision Medicine Requires Better Data Integration

Executive Summary Precision medicine is transforming healthcare by shifting treatment decisions from population-based approaches to strategies tailored to individual patients....
Insights

Why Pharma Supply Chains Need a Resilience-First Strategy

Executive Summary For decades, pharmaceutical supply chains were primarily designed for efficiency. Organizations optimized manufacturing networks, supplier relationships, inventory levels, and...
Commercial

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Orca Bio has officially entered the commercial marketplace after securing the FDA nod for Tregzi, the first engineered cell...
Clinical

BridgeBio Advances Attruby Launch and Three Late-Stage Drug Programs as It Secures New Investment

BridgeBio Pharma is continuing the launch of Attruby while...
Clinical

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

Less than six months after securing hundreds of millions...
Insights

Top 10 Real-World Use Cases for AI in Clinical Development

Executive Summary Artificial intelligence is rapidly becoming one of the most influential technologies in clinical development. Pharmaceutical companies, biotechnology firms,...
Insights

Why Medical Affairs Teams Need New Skills for the Next Decade

Executive Summary Medical affairs has become one of the fastest-evolving functions in the pharmaceutical industry. Traditionally, medical affairs organizations focused on...
Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa for the treatment of thyroid...
Commercial

Zymeworks to Acquire Theravance in $929 Million Deal

Zymeworks has agreed to acquire Theravance in a transaction...
Clinical

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AstraZeneca has released detailed results from two phase 3...
Manufacturing

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected seven pharmaceutical companies to participate in its new PreCheck Pilot...
Clinical

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

AbbVie and Genmab have reported positive topline results from a Phase 3 clinical trial evaluating Epkinly (epcoritamab) in combination...
Clinical

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Vistagen has reported another setback for its lead anxiety treatment fasedienol, after the investigational nasal spray failed to meet...
Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug...
Editorial Team -
Commercial

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Orca Bio has officially entered the commercial marketplace after...
Editorial Team -
Commercial

Novartis Acquires DTx Pharma in a Deal Potentially Worth $1B

Swiss pharmaceutical firm Novartis said on Monday that it...
Commercial

$1.5 Billion Cancer Drug Facility to Be Built by AstraZeneca in Singapore

AstraZeneca is reportedly planning to build a $1.5 billion...

Popular

Most popular life news you must read today

View all articles

Commercial

Information Technology

Alnylam Inks $2B Agreement With Inceptive to Change sIRNA Design With AI Leader

Alnylam has entered into a partnership with the scientist instrumental in developing the technology...
Editorial Team -

Chugai and Gero Partner to Develop Antibodies for Age-Related Diseases Using AI

Chugai Pharmaceutical has entered into a research collaboration with Singapore-based Gero to develop antibody-based...
Editorial Team -

J&J MedTech presents the first Ottava surgical robot clinical cases

Johnson & Johnson MedTech successfully conducted the initial clinical use of Ottava surgical robot...
Editorial Team -

Wisp Launches Weight Care Vertical for Women with Hormonal Imbalances

Common conditions in women such as PCOS, menopause, and endometriosis often lead to hormonal...
Editorial Team -

Regulatory

Regulatory

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug...
Editorial Team -
Insights

Top 10 Reasons Precision Medicine Requires Better Data Integration

Executive Summary Precision medicine is transforming healthcare by shifting treatment...
Insights

Why Pharma Supply Chains Need a Resilience-First Strategy

Executive Summary For decades, pharmaceutical supply chains were primarily designed...
Commercial

Orca Bio Gets FDA Green Light For Tregzi; IPO a Real Possibility

Orca Bio has officially entered the commercial marketplace after...
Commercial

Ipsen to Acquire Memo and Phase 2 BKPyV Antibody Potravitug in Deal Worth Up to €700 Million

French pharmaceutical company Ipsen has agreed to acquire Switzerland-based...

Research & Development

Market Access

Manufacturing

UCB to Build $2 Billion Biologics Manufacturing Facility in Georgia

Belgium-based UCB has announced plans to invest $2 billion...
Manufacturing

Viatris to Cut 10% of Workforce Following Strategic Review and Reports Fire at India Plant

Viatris has outlined plans to reduce its global workforce...

Manufacturing & RegulatoryPOPULAR
Find Your Perfect Music Festival

Insights

Why Pharma Supply Chains Need a Resilience-First Strategy

Executive Summary For decades, pharmaceutical supply chains were primarily designed...
Editorial Team -